Histone deacetylase-1 and -3 protein expression in human breast cancer: A tissue microarray analysis

Breast Cancer Research and Treatment

Volumn 90, Issue 1, 2005, Pages 15-23

  Krusche, Claudia A ^a,d   Wülfing, Pia ^b   Kersting, Christian ^c   Vloet, Anne ^a   Böcker, Werner ^c   Kiesel, Ludwig ^b   Beier, Henning M ^a   Alfer, Joachim ^a  

^a RWTH AACHEN UNIVERSITY   (Germany)

^b UNIVERSITY OF MÜNSTER   (Germany)

^c UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^d NONE   (Germany)

Author keywords

Breast cancer; Cell differentiation; Histone deacetylases; Prognostic marker; Survival

Indexed keywords

ACYLTRANSFERASE; HISTONE DEACETYLASE 1; HISTONE DEACETYLASE 3; UNCLASSIFIED DRUG;

ACETYLATION; ARTICLE; BREAST CARCINOMA; CANCER STAGING; CELL PROLIFERATION; CONTROLLED STUDY; CORRELATION ANALYSIS; DNA MICROARRAY; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCOMPETENT CELL; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; NUCLEOTIDE SEQUENCE; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION;

BREAST NEOPLASMS; CELL DIFFERENTIATION; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; GERMANY; HISTONE DEACETYLASES; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; SURVIVAL RATE; TISSUE ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 16844385708     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10549-004-1668-2     Document Type: Article

References (28)

1. RL Momparler 2003 Cancer epigenetics Oncogene 22 6479 6483
2. S Thiagalingam KH Cheng H Lee N Mineva A Thiagalingam JF Ponte 2003 Histone deacetylases: unique players in shaping the epigenetic histone code Ann NY Acad Sci 983 84 100
3. L Yan X Yang NE Davidson 2001 Role of DNA methylation and histone acetylation in steroid receptor expression in breast cancer J Mammary Gland Biol Neoplasia 6 183 192
4. WD Cress E Seto 2000 Histone deacetylases, transcriptional control, and cancer J Cell Physiol 184 1 16
5. G Lagger A Doetzlhofer B Schuettengruber E Haidweg E Simboeck J Tischler S Chiocca G Suske H Rotheneder E Wintersberger C Seiser 2003 The tumor suppressor p53 and histone deacetylase 1 are antagonistic regulators of the cyclin-dependent kinase inhibitor p21/WAF1/CIP1 gene Mol Cell Biol 23 2669 2679
6. G Lagger D O'Carroll M Rembold H Khier B Schuettengruber C Hauser R Brunmeir T Jenuwein C Seiser 2002 Essential function of histone deacetylase 1 in proliferation control and CDK inhibitor repression EMBO J 21 2672 2681
7. T Davis C Kennedy YE Chiew CL Clarke A de Fazio 2000 Histone deacetylase inhibitors decrease proliferation and modulate cell cycle gene expression in normal mammary epithelial cells Clin Cancer Res 6 4334 4342
8. JC Keen L Yan KM Mack C Pettit D Smith D Sharma NE Davidson 2003 A novel histone deacetylase inhibitor, scriptaid, enhances expression of functional estrogen receptor alpha (ER) in ER negative human breast cancer cells in combination with 5-aza-2′-deoxycytidine Breast Cancer Res Treat 81 177 186
9. ER Jang SJ Lim ES Lee G Jeong TY Kim YJ Bang JS Lee 2004 The histone deacetylase inhibitor trichostatin A sensitizes oestrogen receptor α-negative breast cancer cells to tamoxifen Oncogene 23 1724 1736
10. L Fuino P Bali S Wittmann S Donapaty F Guo H Yamaguchi HG Wang P Atadja K Bhalla 2003 Histone deacetylase inhibitor LAQ824 down-regulates Her-2 and sensitizes human breast cancer cells to trastuzumab, taxotere, gemcitabine, and epothilone B Mol Cancer Ther 2 971 984
11. DM Vigushin S Ali PE Pace N Mirsaidi K Ito I Adcock RC Coombes 2001 Trichostatin A is a histone deacetylase inhibitor with potent antitumor activity against breast cancer in vivo Clin Cancer Res 7 971 976
12. C Kuperwasser J Pinkas GB Hurlbut SP Naber DJ Jerry 2000 Cytoplasmic sequestration and functional repression of p53 in the mammary epithelium is reversed by hormonal treatment Cancer Res 60 2723 2729
13. HS Zhang DC Dean 2001 Rb-mediated chromatin structure regulation and transcriptional repression Oncogene 20 3134 3138
14. KB Glaser J Li MJ Staver RQ Wie DH Albert SK Davidsen 2003 Role of class I and class II histone deacetylases in carcinoma cells using siRNA Biochem Biophy Res Commun 310 529 536
15. MG Guenther O Barak MA Lazar 2001 The SMRT and N-CoR corepressors are activating cofactors for histone deacetylase 3 Mol Cell Biol 21 6091 6101
16. RI Yarden LC Brody 1999 BRCA1 interacts with components of the histone deacetylase complex Proc Natl Acad Sci USA 96 4983 4988
17. J Kononen L Bubendorf A Kallioniemi M Barlund P Schraml S Leighton J Torhorst MJ Milhatsch G Sauter OP Kallioniemi 1998 Tissue microarrays for high-throughput molecular profiling of tumor specimens Nat Med 4 844 847
18. P Wülfing R Diallo C Müller C Wülfing C Poremba A Heinecke A Rody RR Greb W Böcker L Kiesel 2003 Analysis of cyclooxygenase-2 expression in human breast cancer: high throughput tissue microarray analysis J Cancer Res Clin Oncol 129 375 382
19. A Reiner B Neumeister J Spona G Reiner M Schemper R Jakesz 1990 Immunocytochemical localization of estrogen and progesterone receptor and prognosis in human primary breast cancer Cancer Res 50 1057 1061
20. C Poremba W Boecker H Willenbring KL Schafer F Otterbach H Burger R Diallo B Dockhorn-Dworniczak 1998 Telomerase activity in human proliferative breast lesions Int J Oncol 12 641 648
21. Altman DG: Chi square test for trend. In: Practical Statistics for Medical Research. Chapman & Hall, London, 1995, pp 261-265.
22. G Kouraklis S Theocharis 2002 Histone deacetylase inhibitors and anticancer therapy Curr Med Chem Anti-Canc Agents 2 477 484
23. A Goldhirsch JH Glick RD Gelber AS Coates HJ Senn 2001 Meeting highlights: international consensus panel on the treatment of primary breast cancer J Clin Oncol 19 3817 3827
24. A Hoos MJ Urist A Stojadinovic S Mastorides ME Dudas DHJ Leung D Kuo MF Brennan JL Lewis C Cordon-Cardo 2001 Validation of tissue microarrays for immunohistochemical profiling of cancer specimens using the example of human fibroblastic tumours Am J Pathol 158 1245 1251
25. LJ van't Veer H Dai MJ vande Vijver YD He AAM Hart M Mao HL Peterse K vander Kooy MJ Marton AT Witteveen GJ Schreiber RM Kerkhoven C Roberts PS Linsley R Bernards SH Friend 2002 Gene expression profiling predicts clinical outcome of breast cancer Nature 415 530 536
26. D Santini C Ceccarelli M Taffurelli S Pileri D Marrano 1996 Differentiation pathways in primary invasive breast carcinoma as suggested by intermediate filament and biopathological marker expression J Pathol 179 386 391
27. RB Clarke 2003 Steroid receptors and proliferation in human breast Steroids 68 789 794
28. H Kawai H Li S Avraham S Jiang HK Avraham 2003 Over expression of histone deacetylase HDAC1 modulates breast cancer progression by negative regulation of oestrogen receptor alpha Int J Cancer 107 353 358